Renal Cell Cancer, Recurrent Completed Phase 1 Trials for RG-4733 (DB11870)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01198184Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsTreatment